Sema4 to Participate at Three Upcoming Investor Conferences in November

Rhea-AI Summary

Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform, announced participation in three upcoming virtual investor conferences. Key events include the Stifel 2021 Virtual Healthcare Conference on November 16 at 2:40 p.m. ET, a Canaccord Genuity forum on November 18 at 11:30 a.m. ET, and the Jefferies London Healthcare Conference featuring 1x1 meetings on November 19. Live and archived webcasts will be available on the Sema4 investor relations website, enhancing investor engagement and information access.

STAMFORD, Conn., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that company management will participate at the following virtual investor conferences:

• Stifel 2021 Virtual Healthcare Conference
  Formal presentation and 1x1s on Tuesday, November 16^th, 2021 at 2:40 p.m. ET

• Canaccord Genuity Virtual MedTech, Diagnostics, and Digital Health & Services Forum
  Fireside chat and 1x1s on Thursday, November 18^th, 2021 at 11:30 a.m. ET

• Jefferies London Healthcare Conference
  1x1s on Friday, November 19^th, 2021

Live and archived webcasts of the Stifel and Canaccord presentations will be available on the “Events” section of the Sema4 investor relations website at https://ir.sema4.com/.

About Sema4

Sema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Centrellis®, our innovative health intelligence platform, is enabling us to generate a more complete understanding of disease and wellness and to provide science-driven solutions to the most pressing medical needs. Sema4 believes that patients should be treated as partners, and that data should be shared for the benefit of all.

For more information, please visit sema4.com and connect with Sema4 on Twitter, LinkedIn, Facebook and YouTube.

Investor Relations Contact:
Joel Kaufman
Sema4
investors@sema4.com

Media Contact:
Radley Moss
Sema4
radley.moss@sema4.com

FAQ

When is Sema4 participating in the Stifel 2021 Virtual Healthcare Conference?

Sema4 will participate in the Stifel 2021 Virtual Healthcare Conference on November 16, 2021, at 2:40 p.m. ET.

What is the schedule for Sema4's participation in upcoming investor conferences?

Sema4 will participate in the following conferences: Stifel on November 16, Canaccord Genuity on November 18, and Jefferies on November 19, 2021.

Where can I find the webcasts for Sema4's investor presentations?

Live and archived webcasts for Sema4's presentations will be available on their investor relations website.

What are the dates of the Canaccord Genuity Virtual MedTech Forum?

The Canaccord Genuity Virtual MedTech, Diagnostics, and Digital Health & Services Forum will take place on November 18, 2021.

What is the significance of Sema4's presentations at these conferences?

Sema4's presentations aim to engage investors and share insights on their AI-driven genomic and clinical data intelligence platform.